MM-II

· Sun Pharmaceutical Industries Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MM-II, covering 2024-08-29 to 2024-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of MM-II for Treatment of Knee Pain in Subjects With Symptomatic Knee Osteoarthritis [Phase 2]

See pricing